Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition by Asor, R

Characterising biomolecular interactions and dynamics with mass photometry by Asor, R, Kukura, P

Lifting the concentration limit of mass photometry by PEG nanopattering by Kratochvil, J, Asor, R, Helmi, S, Struwe, W, Kukura, P

Effect of temperature and nucleotide on the binding of BiP chaperone to a protein substrate by Rivera, M, Burgos-Bravo, F, Engelberger, F, Asor, R, Lagos-Espinoza, MIA, Figueroa, M, Kukura, P, Ramírez-Sarmiento, CA, Baez, M, Smith, SB, Wilson, CAM

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking by Asor, R, Olerinyova, A, Kushwah, MS, Soltermann, F, Rudden, LP, Vasiljevic, S, Brun, J, Hensen, M, Hill, M, Degiacomi, M, Zitzmann, N, Struwe, WB, Kukura, P

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking by Asor, R, Olerinyova, A, Kushwah, MS, Soltermann, F, Powell Rudden, L, Vasiljevic, S, Brun, J, Hensen, M, Hill, M, Degiacomi, M, Zitzmann, N, Struwe, WB, Kukura, P

Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies by Asor, R, Olerinyova, A, Burnap, SA, Kushwah, MS, Hensen, M, Vasiljevic, S, Chang, L, Dejnirattisa, W, Supasa, P, Stuart, DI, Screaton, GR, Zitzmann, N, Benesch, JLP, Struwe, WB, Kukura, P

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition by Asor, R, Olerinyova, A, Burnap, SA, Kushwah, M, Soltermann, F, Rudden, LSP, Hensen, M, Vasiljevic, S, Brun, J, Hill, M, Chang, L, Dejnirattisa, W, Supasa, P, Mogkolsapaya, J, Zhou, D, Stuart, D, Screaton, GR, Degiacomi, M, Zitzmann, N, Benesch, J, Struwe, W, Kukura, P